Peptide 20, a GIPR/GLP-1R/GCGR triagonist (currently in phase 1 clinical trial) 17 with balanced potency at the three receptors, is evolved from a GLP-1R/GCGR dualagonist 18 through iterative sequence refinement and modification (Fig
Since cognitive behavioral therapy for insomnia (CBTi) can enhance sleep quality and support endogenous antioxidant defenses, combining natural sleep interventions with pharmacological NRF2 activators such as dimethyl fumarate and sulforaphane may reinforce these pathways, stabilizing sleep patterns, reducing pain hypersensitivity, and improving fatigue
Thereafter, the observation of incretin activity after the inactivation of GIP suggested the existence of other molecules with an incretin effect
Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome
[12] Surgery is the most common method of treating peripheral nerve sheath tumors
Regarding the treatment of obesity, we expect SMG to be approved by more countries FDA in the future
